Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/36040
Title: Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
Authors: DAUW, Jeroen 
Lelonek, Malgorzata
Zegri-Reiriz, Isabel
Paredes-Paucar, Cynthia P.
Zara, Cornelia
George, Varghese
Cobo-Marcos, Marta
Knappe, Dorit
Shchekochikhin, Dmitry
Lekhakul, Annop
Klincheva, Milka
Frea, Simone
Miro, Oscar
Barker, Diane
Borbely, Attila
Nasr, Samer
Doghmi, Nawal
de la Espriella, Rafael
Singh, Jagdeep S.
Bovolo, Virginia
Fialho, Ines
Ross, Noel T.
van den Heuvel, Marcel
Benkouar, Riad
Findeisen, Hajo
Alhaddad, Imad A.
Al Balbissi, Kais
Barge-Caballero, Gonzalo
Ghazi, Azmee M.
BRUCKERS, Liesbeth 
MARTENS, Pieter 
MULLENS, Wilfried 
Issue Date: 2021
Publisher: WILEY PERIODICALS, INC
Source: ESC Heart Failure,
Abstract: Aims Although acute heart failure (AHF) with volume overload is treated with loop diuretics, their dosing and type of administration are mainly based upon expert opinion. A recent position paper from the Heart Failure Association (HFA) proposed a step-wise pharmacologic diuretic strategy to increase the diuretic response and to achieve rapid decongestion. However, no study has evaluated this protocol prospectively. Methods and results The Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure (ENACT-HF) study is an international, multicentre, non-randomized, open-label, pragmatic study in AHF patients on chronic loop diuretic therapy, admitted to the hospital for intravenous loop diuretic therapy, aiming to enrol 500 patients. Inclusion criteria are as follows: at least one sign of volume overload (oedema, ascites, or pleural effusion), use >= 40 mg of furosemide or equivalent for >1 month, and a BNP > 250 ng/L or an N-terminal pro-B-type natriuretic peptide > 1000 pg/L. The study is designed in two sequential phases. During Phase 1, all centres will treat consecutive patients according to the local standard of care. In the Phase 2 of the study, all centres will implement a standardized diuretic protocol in the next cohort of consecutive patients. The protocol is based upon the recently published HFA algorithm on diuretic use and starts with intravenous administration of two times the oral home dose. It includes early assessment of diuretic response with a spot urinary sodium measurement after 2 h and urine output after 6 h. Diuretics will be tailored further based upon these measurements. The study is powered for its primary endpoint of natriuresis after 1 day and will be able to detect a 15% difference with 80% power. Secondary endpoints are natriuresis and diuresis after 2 days, change in congestion score, change in weight, in-hospital mortality, and length of hospitalization. Conclusions The ENACT-HF study will investigate whether a step-wise diuretic approach, based upon early assessment of urinary sodium and urine output as proposed by the HFA, is feasible and able to improve decongestion in AHF with volume overload.
Notes: Mullens, W (corresponding author), Ziekenhuis Oost Limburg, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium.
wilfried.mullens@zol.be
Keywords: Acute heart failure; Diuretics; Urinary sodium; Decongestion; Protocol
Document URI: http://hdl.handle.net/1942/36040
ISSN: 2055-5822
e-ISSN: 2055-5822
DOI: 10.1002/ehf2.13666
ISI #: 000712411900001
Rights: © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License,
Category: A1
Type: Journal Contribution
Validations: ecoom 2022
Appears in Collections:Research publications

Show full item record

WEB OF SCIENCETM
Citations

18
checked on Apr 22, 2024

Page view(s)

22
checked on Jul 22, 2022

Download(s)

6
checked on Jul 22, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.